Table 1.
Characteristic | All patients (n = 743) Number (%) or median (IQR) |
HIV-monoinfected (n = 694) Number (%) or median (IQR) |
HBV/HIV coinfected (n = 49) Number (%) or median (IQR) |
Odds ratio (95% CI) |
P value |
---|---|---|---|---|---|
Sex | |||||
Males | 259 (34.9) | 242 (34.8) | 17 (34.7) | 0.99 (0.54–1.82) | 0.98 |
Age (years) | 37 (IQR 30–44) | 37 (30–44) | 38 (30–43) | 0.99 (0.97–1.02) | 0.83 |
≥39 | 329 (44.28) | 309 (44.52) | 20 (40.82) | 1.26 (1.01–1.45) | 0.002 |
Age group ≥ 39 | 45 (41–51) | 45 (41–51) | 47.5 (41–51) | 1.00 (0.95–1.06) | 0.91 |
Age group < 39 | 31 (25–35) | 31 (25–35) | 30 (26–36) | 1.01 (0.95–1.1) | 0.75 |
Marital status | |||||
Single | 189 (25.4) | 175 (25.2) | 14 (28.6) | 1.19 (0.62–2.26) | 0.61 |
Married | 300 (40.4) | 281 (40.5) | 19 (38.8) | 0.93 (0.51–1.69) | 0.81 |
Divorced | 132 (17.8) | 121 (17.4) | 11 (22.5) | 0.37 (0.68–2.78) | 0.38 |
Widowed | 122 (16.4) | 117 (16.9) | 5 (10.2) | 0.56 (0.22–1.44) | 0.23 |
AIDS stage | |||||
1 or 2 | 386 (51.9) | 367 (52.9) | 19 (38.8) | ||
3 or 4 | 357 (48.1) | 327 (47.1) | 30 (61.2) | 1.77 (0.98–3.21) | 0.006 |
Baseline CD4 (cells/µl) | 256 (123–458) | 266 (132–465) | 158 (88.5–295) | 1.46 (0.76–2.84) | 0.02 |
CD4 < 200 | 251 (33.8) | 218 (31.4) | 33 (67.4) | 4.50 (2.43–8.36) | <0.001 |
CD4 ≥ 200 group | 400 (290–591) | 513 (308–583) | 399 (286–594) | 1.00 (0.99–1.00) | 1.00 |
CD4 < 200 group | 91 (37–151) | 123 (49–162) | 87 (36–150) | 1.00 (0.99–1.01) | 0.23 |
Liver enzymes (IU/l) | |||||
AST | 26 (19.5–37) | 26 (19.6–37) | 30.2 (18.8–57.3) | 1.01 (1.00–1.02) | <0.001 |
AST > 40 | 254 (34.2) | 230 (33.1) | 24 (48.5) | 1.94 (1.08–3.46) | 0.03 |
ALT | 19 (13–30) | 18.3 (13–29) | 25.9 (13–45) | 1.01 (1.00–1.02) | 0.02 |
ALT > 41 | 203 (27.32) | 182 (26.22) | 21 (42.86) | 2.11 (1.17–3.81) | 0.01 |
Platelets (cells/ul) | 247 (189–330) × 103 | 250 (191–331) × 103 | 203 (170–275) × 103 | 1.04 (0.83–1.05) | 0.05 |
<150 × 103 | 63 (8.5) | 56 (8.1) | 7 (14.3) | 0.53 (0.23–1.23) | 0.14 |